Magenta Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/09/2023 | Q3 2023 | -$3.78 | $0 | |||
| 08/03/2023 | Q2 2023 | $0.19 | -$1.03 | -1.22 | $0 | |
| 05/15/2023 | Q1 2023 | -$8.21 | $0 | |||
| 03/23/2023 | Q4 2022 | -$7.38 | $0 | |||
| 11/03/2022 | Q3 2022 | $0.31 | -$5.53 | -5.84 | $0 | |
| 08/04/2022 | Q2 2022 | $0.37 | -$0.29 | -0.66 | $0 | |
| 05/16/2022 | Q1 2022 | $0.34 | -$0.39 | -0.73 | $0 | |
| 03/08/2022 | Q4 2021 | $0.32 | -$0.33 | -0.65 | $0 | |
| 11/04/2021 | Q3 2021 | $0.32 | -$0.30 | -0.62 | $0 | |
| 08/05/2021 | Q2 2021 | $0.35 | -$0.32 | -0.67 | $0 | |
| 05/06/2021 | Q1 2021 | $0.40 | -$0.36 | -0.76 | $0 | |
| 03/03/2021 | Q4 2020 | $0.43 | -$0.38 | -0.81 | $0 | |
| 11/05/2020 | Q3 2020 | $0.45 | -$0.37 | -0.82 | $0 | |
| 08/06/2020 | Q2 2020 | $0.53 | -$0.48 | -1.01 | $0 | |
| 05/07/2020 | Q1 2020 | $0.61 | -$0.51 | -1.12 | $0 | |
| 03/03/2020 | Q4 2019 | $0.58 | -$0.59 | -1.17 | $0 | |
| 11/13/2019 | Q3 2019 | $0.53 | -$0.54 | -1.07 | $0 | |
| 08/08/2019 | Q2 2019 | $0.49 | -$0.48 | -0.97 | $0 | |
| 05/09/2019 | Q1 2019 | $0.53 | -$0.44 | -0.97 | $0 | |
| 03/19/2019 | Q4 2018 | -$0.50 | $0 |
Magenta Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Magenta Therapeutics, Inc.'s earnings date?
Magenta Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 1st, 2023 based off last year's report dates.
-
Did Magenta Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Magenta Therapeutics, Inc. (:MGTA) reported $-0.27 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.3 by $0.03.
-
How can I listen to Magenta Therapeutics, Inc.'s earnings conference call?
The conference call for Magenta Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Magenta Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Magenta Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Magenta Therapeutics, Inc. generate each year?
Magenta Therapeutics, Inc. (:MGTA) has a recorded net income of $0. Magenta Therapeutics, Inc. has generated $-23.05 earnings per share over the last four quarters.
-
What is Magenta Therapeutics, Inc.'s price-to-earnings ratio?
Magenta Therapeutics, Inc. (:MGTA) has a price-to-earnings ratio of -0.15 and price/earnings-to-growth ratio is -0.02.
